Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,487.03 +13.80 (+0.25%) Dow
38,834.86 +56.76 (+0.15%) Nasdaq
17,862.23 +5.21 (+0.03%) Bitcoin USD
66,030.10 +941.58 (+1.45%) CMC Crypto 200
1,374.56 -8.10 (-0.59%)
ORIC Nov 2024 20.000 call
| Previous close | 0.3500 |
| Open | 0.3500 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 20.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.3500 - 0.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
GlobeNewswireORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 3, 2024 (the “Grant Date”), ORIC granted a total of 30,000 non-qualified stock options and 4,800 restricted stock units to three new non-executive employees who began their employment with ORIC in May 2024. These inducement grants wer
- GlobeNewswire
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in June: Jefferies Global Healthcare Conference – Participating in a fireside chat on Wednesday, June 5, 2024, at 10:30 a.m. ET. Goldman Sachs 45th Annual Global Healthcare Con
Simply Wall St.We Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
